| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adipokines as drug targets in joint and bone disease
|
Scotece, Morena
|
|
2014
|
19 |
3 |
p. 241-258
18 p.
|
artikel
|
| 2 |
Bearing arms against osteoarthritis and sarcopenia: when cartilage and skeletal muscle find common interest in talking together
|
De Ceuninck, Frédéric
|
|
2014
|
19 |
3 |
p. 305-311
7 p.
|
artikel
|
| 3 |
Can pharmaco-electroencephalography help improve survival of central nervous system drugs in early clinical development?
|
Wilson, Frederick J.
|
|
2014
|
19 |
3 |
p. 282-288
7 p.
|
artikel
|
| 4 |
Computational proteomics: designing a comprehensive analytical strategy
|
Goh, Wilson Wen Bin
|
|
2014
|
19 |
3 |
p. 266-274
9 p.
|
artikel
|
| 5 |
Contents page 2
|
|
|
2014
|
19 |
3 |
p. iii-
1 p.
|
artikel
|
| 6 |
Contents page 1
|
|
|
2014
|
19 |
3 |
p. i-
1 p.
|
artikel
|
| 7 |
Controlling 2-arachidonoylglycerol metabolism as an anti-inflammatory strategy
|
Alhouayek, Mireille
|
|
2014
|
19 |
3 |
p. 295-304
10 p.
|
artikel
|
| 8 |
Driving external chemistry optimization via operations management principles
|
Bi, F. Christopher
|
|
2014
|
19 |
3 |
p. 289-294
6 p.
|
artikel
|
| 9 |
Drug enterohepatic circulation and disposition: constituents of systems pharmacokinetics
|
Gao, Yu
|
|
2014
|
19 |
3 |
p. 326-340
15 p.
|
artikel
|
| 10 |
In vitro–in vivo extrapolation of drug-induced proarrhythmia predictions at the population level
|
Polak, Sebastian
|
|
2014
|
19 |
3 |
p. 275-281
7 p.
|
artikel
|
| 11 |
Is bisphosphonate therapy compromised by the emergence of adverse bone disorders?
|
Verron, E.
|
|
2014
|
19 |
3 |
p. 312-319
8 p.
|
artikel
|
| 12 |
Natural products as lead structures: chemical transformations to create lead-like libraries
|
Pascolutti, Mauro
|
|
2014
|
19 |
3 |
p. 215-221
7 p.
|
artikel
|
| 13 |
Protein disulfide isomerase: a promising target for cancer therapy
|
Xu, Shili
|
|
2014
|
19 |
3 |
p. 222-240
19 p.
|
artikel
|
| 14 |
Reducing attrition in drug development: smart loading preclinical safety assessment
|
Roberts, Ruth A.
|
|
2014
|
19 |
3 |
p. 341-347
7 p.
|
artikel
|
| 15 |
Targeting the nucleolus for cancer-specific activation of p53
|
Drygin, Denis
|
|
2014
|
19 |
3 |
p. 259-265
7 p.
|
artikel
|
| 16 |
The conformational musings of a medicinal chemist
|
Finch, Harry
|
|
2014
|
19 |
3 |
p. 320-325
6 p.
|
artikel
|
| 17 |
The development speed paradox: can increasing development speed reduce R&D productivity?
|
Lendrem, Dennis W.
|
|
2014
|
19 |
3 |
p. 209-214
6 p.
|
artikel
|
| 18 |
The utility of biomarkers in CNS drug development
|
Palmer, Alan M.
|
|
2014
|
19 |
3 |
p. 201-203
3 p.
|
artikel
|
| 19 |
Treating osteoporosis by targeting parathyroid hormone to bone
|
Ponnapakkam, T.
|
|
2014
|
19 |
3 |
p. 204-208
5 p.
|
artikel
|
| 20 |
Virtual pharmaceutical companies: collaborating flexibly in pharmaceutical development
|
Forster, Simon P.
|
|
2014
|
19 |
3 |
p. 348-355
8 p.
|
artikel
|
Tijdschrift beschrijving